吸入麻酔の市場規模・シェア・成長分析 (薬剤別、エンドユーザー別、地域別)：産業予測 (2024～2031年)

世界の吸入麻酔の市場規模は、2022年に約14億6,000万米ドルと評価され、2023年の16億米ドルから上昇し、予測期間中（2024～2031年）に9.4%のCAGRで成長し、2031年には32億8,000万米ドルに達すると予測されています。

吸入麻酔市場は、いくつかの重要な要因によって、今後数年間で大きく成長する見込みです。慢性疾患の有病率の上昇と医療施設における麻酔需要の増加は、吸入麻酔製品の売上を大幅に押し上げると予想されます。さらに、世界の外科手術の増加は、分析期間中およびその後も吸入麻酔の需要を高める上で極めて重要な役割を果たしています。麻酔技術の革新と高度な麻酔技術の開発への投資拡大が、市場拡大の新たな道を開いています。さらに、特殊な小児麻酔に対するニーズの高まりとともに、高齢者人口の増加が吸入麻酔市場の長期的な成長にさらに貢献すると思われます。しかし、麻酔に伴う潜在的な健康合併症、熟練した麻酔科医の不足、高度な麻酔デリバリーシステムに関連する高コストといった課題は、長期的には吸入麻酔市場の需要を阻害する可能性があります。全体として、乗り越えなければならない障害はあるもの、吸入麻酔の全体的な見通しは依然として良好であり、医療分野における成長とイノベーションの機会は数多く存在します。

目次

イントロダクション

• 分析目的
• 定義
• 市場範囲

分析手法

• 情報調達
• 二次データソースと一次データソース
• 市場規模予測
• 市場の想定と制限

エグゼクティブサマリー

• 市場の概要と見通し
• 需給動向の分析
• セグメント別の機会分析

市場力学と見通し

• 市場力学
  • 促進要因
  • 機会
  • 抑制要因
  • 課題
• ポーターの分析

主な市場の考察

• 主な成功要因
• 競合の程度
• 主な投資機会
• 市場のエコシステム
• バリューチェーン分析
• ケーススタディ分析
• 規制情勢
• 技術分析

吸入麻酔市場：薬剤別

• 市場概要
• セボフルラン
• デスフルラン
• イソフルラン
• その他

吸入麻酔市場：用途別

• 市場概要
• 誘導
• 維持

吸入麻酔市場：最終用途別

• 市場概要
• 病院
• 外来手術センター
• その他

吸入麻酔市場：地域別

• 市場概要
• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ
• 中東・アフリカ（MEA）
  • 湾岸協力会議 (GCC) 諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情勢

• 上位5社の比較
• 主要企業の市場ポジショニング（2023年）
• 主な市場企業が採用した戦略
• 市場における最近の活動
• 主要企業の市場シェア（2023年）

主要企業プロファイル

• Baxter International Inc. (米国)
• Halocarbon Products Corporation (米国)
• Piramal Critical Care (インド)
• AbbVie Inc. (米国)
• Fresenius Kabi AG (ドイツ)
• GE Healthcare (米国)
• Hikma Pharmaceuticals PLC (英国)
• Linde Plc (アイルランド)
• Dragerwerk AG & Co. KGaA (ドイツ)
• Mindray Medical International Limited (中国)
• Shenzhen Landwind Industry Co., Ltd. (中国)
• Medtronic Plc (アイルランド)
• Medtronic Plc (アイルランド)
• Smith's Group plc (英国)
• Teleflex Incorporated (米国)
• Masimo Corporation (米国)
• Penlon Ltd. (英国)
• Dameca A/S（デンマーク）
• Soma Technology, Inc. (米国)
• Narang Medical Limited (インド)

Global Inhalation Anesthesia Market size was valued at around USD 1.46 billion in 2022 and is expected to rise from USD 1.60 billion in 2023 to reach a value of USD 3.28 billion by 2031, at a CAGR of 9.4% over the forecast period (2024-2031).

The inhalation anesthesia market is poised for substantial growth in the coming years, driven by several key factors. The rising prevalence of chronic diseases and an increasing demand for anesthesia in healthcare facilities are expected to significantly boost sales of inhalation anesthesia products. Additionally, the global uptick in surgical procedures plays a pivotal role in elevating the demand for inhalation anesthesia throughout the study period and beyond. Innovations in anesthetic technologies and heightened investments in developing advanced anesthetic techniques are opening new avenues for market expansion. Furthermore, the growing geriatric population, alongside the rising need for specialized pediatric anesthesia, will further contribute to the long-term growth of the inhalation anesthesia market. However, challenges such as potential health complications associated with anesthesia, a shortage of skilled anesthesiologists, and the high costs associated with advanced anesthesia delivery systems may hinder market demand in the long run. Overall, while there are obstacles to navigate, the overall outlook for inhalation anesthesia remains positive, with numerous opportunities for growth and innovation in the healthcare sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Inhalation Anesthesia market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Inhalation Anesthesia Market Segmental Analysis

Global Inhalation Anesthesia Market is segmented by Drug, Application End Use and region. Based on Drug, the market is segmented into Sevoflurane, Desflurane, Isoflurane, and Others. Based on Application, the market is segmented into Induction, and Maintenance. Based on End-Use, the market is segmented into Hospitals, Ambulatory Surgical Centers, and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Inhalation Anesthesia Market

The escalating prevalence of chronic diseases worldwide is driving a rising number of surgical procedures, significantly influencing the Global Inhalation Anesthesia market. As surgical interventions become increasingly common, the demand for effective and safe anesthesia options-such as inhalation agents-grows correspondingly. This trend highlights the essential role of anesthesia in facilitating complex surgeries and improving patient outcomes. Furthermore, advancements in inhalation anesthesia technologies and increasing awareness of their benefits enhance their adoption across healthcare settings. As healthcare systems adapt to address the surge in surgical needs, the inhalation anesthesia market is poised for substantial growth, creating lucrative opportunities for stakeholders.

Restraints in the Global Inhalation Anesthesia Market

One of the significant market restraints for the Global Inhalation Anesthesia market is the declining number of skilled anesthesiologists proficient in administering inhalation anesthesia. As the demand for surgical procedures rises globally, the shortage of qualified professionals willing and able to operate advanced anesthesia systems may hinder the effective implementation of inhalation anesthesia techniques. This scarcity is especially pronounced in underdeveloped and developing regions, where healthcare infrastructure may be lacking. Consequently, the insufficient pool of skilled anesthesiologists poses a barrier to market growth by limiting the accessibility and utilization of inhalation anesthesia, thereby potentially impacting patient outcomes and overall market expansion.

Market Trends of the Global Inhalation Anesthesia Market

The Global Inhalation Anesthesia market is witnessing a significant trend towards sustainable anesthetic agents, driven by increasing environmental awareness and stringent regulatory mandates. Manufacturers are prioritizing the development of inhalation anesthetics that minimize ecological impact, aligning with global sustainability goals. This shift not only addresses growing concerns about greenhouse gas emissions associated with traditional anesthetics but also positions companies favorably in a competitive landscape. By innovating in eco-friendly anesthetic formulations and practices, businesses can enhance their market presence and appeal to environmentally conscious healthcare providers, ultimately reshaping the future dynamics of the inhalation anesthesia industry.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factor
• Degree of Competition
• Top Investment Pockets
• Ecosystem of the Market
• Value Chain Analysis
• Case Study Analysis
• Regulatory Landscape
• Technology Analysis

Inhalation Anesthesia Market, By Drug

• Market Overview
• Sevoflurane
• Desflurane
• Isoflurane
• Others

Inhalation Anesthesia Market, By Application

• Market Overview
• Induction
• Maintenance

Inhalation Anesthesia Market, By End-Use

• Market Overview
• Hospitals
• Ambulatory Surgical Centers
• Others

Healthcare Analytical Testing Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Baxter International Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Halocarbon Products Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Piramal Critical Care (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AbbVie Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius Kabi AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hikma Pharmaceuticals PLC (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Linde Plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dragerwerk AG & Co. KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mindray Medical International Limited (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shenzhen Landwind Industry Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic Plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic Plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smith's Group plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teleflex Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Masimo Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Penlon Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dameca A/S (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Soma Technology, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Narang Medical Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments